Purpura, Thrombocytopenic, Idiopathic
Showing 51 - 75 of 3,370
Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069)
Enrolling by invitation
- Idiopathic Thrombocytopenic Purpura
- GNR-069
-
Irkutsk, Irkutsk Region, Russian Federation
- +12 more
Aug 5, 2022
Immune Thrombocytopenia Trial in Beijing (Cyclosporine Oral Product, Prednisone)
Not yet recruiting
- Immune Thrombocytopenia
- Cyclosporine Oral Product
- Prednisone
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Jul 14, 2022
Immune Thrombocytopenia, Bruton Tyrosine Kinase Trial in Beijing (Zanubrutinib)
Recruiting
- Immune Thrombocytopenia
- Bruton Tyrosine Kinase
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Mar 6, 2022
Primary Immune Thrombocytopenia Trial in Guadalajara (Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet)
Completed
- Primary Immune Thrombocytopenia
- Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet
-
Guadalajara, Jalisco, MexicoHospital Civil de Guadalajara Fray Antonio Alcalde
Sep 20, 2022
Crohn Disease, Ulcerative Colitis, Celiac Disease Trial in Hong Kong (Fecal Microbiota Transplantation)
Recruiting
- Crohn Disease
- +26 more
- Fecal Microbiota Transplantation
-
Hong Kong, Shatin, Hong KongThe Chinese University of Hong Kong
Feb 10, 2022
Immune Thrombocytopenia Trial in Houston (Acetaminophen and Diphenhydramine Only Product)
Recruiting
- Immune Thrombocytopenia
- Acetaminophen and Diphenhydramine Only Product
-
Houston, TexasTexas Children's Hospital
Apr 11, 2022
Idiopathic Thrombocytopenic Purpura Trial in Cairo (Eltrombopag, conventional)
Completed
- Idiopathic Thrombocytopenic Purpura
-
Cairo, EgyptAinshams University , Faculty of medicine , Pediatric Hematology
Oct 26, 2021
Immune Thrombocytopenia Trial in Beijing (Prednisone, Recombinant Human TPO)
Recruiting
- Immune Thrombocytopenia
- Prednisone
- Recombinant Human TPO
-
Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Apr 17, 2022
Immune Thrombocytopenia Trial in Sohag (Genotyping of rs1980422-related single-nucleotide polymorphisms by real time PCR)
Not yet recruiting
- Immune Thrombocytopenia
- Genotyping of rs1980422-related single-nucleotide polymorphisms by real time PCR
-
Sohag, EgyptSohag University Hospital
Jul 19, 2022
Immune Thrombocytopenic Purpura (ITP) Trial in Worldwide (Immune Globulin Intravenous (Human), 10% Triple Virally Reduced
Completed
- Immune Thrombocytopenic Purpura (ITP)
- Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution
-
Brno, Czechia
- +10 more
Apr 29, 2021
Immune Thrombocytopenia Trial in Beijing (Iguratimod)
Not yet recruiting
- Immune Thrombocytopenia
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Mar 21, 2022
Immune Thrombocytopenia, Purpura, Thrombocytopenic Trial in Jinan (Atorvastatin 20mg, Atorvastatin 10mg, Dexamethasone)
Not yet recruiting
- Immune Thrombocytopenia
- Purpura, Thrombocytopenic
- Atorvastatin 20mg
- +2 more
-
Jinan, Shandong, ChinaQilu hospital, Shandong University
Aug 30, 2021
Immune Thrombocytopenia Trial in Beijing (Orelabrutinib)
Not yet recruiting
- Immune Thrombocytopenia
-
Beijing, Beijing, ChinaPeking University Institute of Hematology
Nov 6, 2021
Immune Thrombocytopenia, Autoimmune Hemolytic Anemia Trial in Toulouse (no specific intervention)
Recruiting
- Immune Thrombocytopenia
- Autoimmune Hemolytic Anemia
- no specific intervention
-
Toulouse, FranceService de Médecine Interne
Jan 24, 2022
Purpura, Thrombocytopenic, Idiopathic, Autoimmune Thrombocytopenic Purpura, Purpura, Thrombocytopenic, Autoimmune Trial in
Terminated
- Purpura, Thrombocytopenic, Idiopathic
- +2 more
- veltuzumab
-
Los Angeles, California
- +7 more
Aug 12, 2021
Immune Thrombocytopenia, Treatment Trial in Tianjin (Zanubrutinib)
Recruiting
- Immune Thrombocytopenia
- Treatment
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 19, 2022
Evaluate Safety and Effectiveness of Hetrombopag in ITP or AA
Not yet recruiting
- Primary Immune Thrombocytopenia
- Aplastic Anemia
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Apr 11, 2022
Immune Thrombocytopenia Trial (Zanubrutinib, Dexamethasone)
Not yet recruiting
- Immune Thrombocytopenia
- (no location specified)
May 6, 2022
The Serum Lipid Profiles in ITP: a Retrospective Study
Completed
- Immune Thrombocytopenia
- ITP patients
-
Jinan, Shandong, ChinaQilu hospital of Shandong university
Oct 14, 2021
Immune Thrombocytopenia, Blood Coagulation Disorders, Thrombocytopenia Trial in Beijing (Sitagliptin, Danazol)
Recruiting
- Immune Thrombocytopenia
- +3 more
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Apr 25, 2022
Primary Immune Thrombocytopenia Trial (2.5mg/d Hetrombopag)
Not yet recruiting
- Primary Immune Thrombocytopenia
- 2.5mg/d Hetrombopag
- (no location specified)
Mar 28, 2022
Risk Factors for Thrombosis in Immune Thrombocytopenia
Completed
- Immune Thrombocytopenia
-
Toulouse, FranceUniversity Hospital Toulouse
Sep 3, 2021
Primary Immune Thrombocytopenia (ITP) Trial (Combination of Rituximab with subcutaneous belimumab, Combination of Rituximab with
Not yet recruiting
- Primary Immune Thrombocytopenia (ITP)
- Combination of Rituximab with subcutaneous belimumab
- Combination of Rituximab with subcutaneous placebo
- (no location specified)
Apr 15, 2022
Immune Thrombocytopenia Trial in Beijing (Zanubrutinib, Eltrombopag)
Not yet recruiting
- Immune Thrombocytopenia
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
May 6, 2022